By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
Achillion Pharmaceuticals, Inc. (ACHN) Added To The Russell 2000 And Russell Microcap Indexes 7/2/2014 7:10:58 AM
AbbVie (ABBV) And Johnson & Johnson (JNJ) Were In A Bidding War For Idenix Pharmaceuticals, Inc. (IDIX), Will Achillion Pharmaceuticals, Inc. (ACHN) Be The Next Target? 6/12/2014 5:38:38 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences 6/11/2014 7:28:09 AM
Achillion Pharmaceuticals, Inc. (ACHN) Surges As The FDA Lifts Hold On Hepatitis C Trial; Stock Up +83.29% At Market Close (June 10, 2014) 6/10/2014 7:27:30 AM
Achillion Pharmaceuticals, Inc. (ACHN) Reports First Quarter 2014 Financial Results 5/7/2014 8:59:24 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Three Upcoming Investor Conferences 5/1/2014 9:18:25 AM
Achillion Pharmaceuticals, Inc. (ACHN) Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, For HCV 4/30/2014 4:01:47 PM
Achillion Pharmaceuticals, Inc. (ACHN) Announces Oral Presentations Given At APASL 2014 Detailing Clinical Activity Of ACH-3102, Second-Generation NS5A Inhibitor, Against Genotype 1b HCV 3/14/2014 9:33:41 AM
Achillion Pharmaceuticals, Inc. (ACHN) Reports 2013 Fourth Quarter And Year-End Financial Results 3/7/2014 8:37:34 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences 2/10/2014 8:56:50 AM
12345678910...
//-->